Heska

Heska was a leading provider of advanced diagnostic solutions—especially immunodiagnostics/allergy testing—and imaging equipment to the global veterinary market with a focus on companion animal health. Its flagship technologies include the ALLERCEPT serum IgE allergy tests based on Fc-epsilon receptor technology and innovative digital cytopathology platforms like HeskaView Telecytology. The company also offered routine chemistry panels, hematological analyzers (“Element Series”), infectious disease rapid tests, oncology screening (“Nu.Q” canine cancer blood test), imaging systems (X-ray/digital radiography), ultrasound devices, telemedicine services powered by AI interpretation tools—all aimed at empowering veterinarians to deliver high-quality care efficiently.

In June 2023 it was acquired by Mars Inc.’s Antech division—one of the world’s largest networks of reference labs/pet healthcare providers—integrating its product lines into an even broader suite serving clinics globally through both direct sales/service models and laboratory partnerships across North America & Europe[1][3].